Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000875320-25-000073
Filing Date
2025-02-14
Accepted
2025-02-14 16:18:59
Documents
1
Period of Report
2025-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1739567930.html 4  
1 FORM 4 wk-form4_1739567930.xml 4 3262
  Complete submission text file 0000875320-25-000073.txt   4690
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VERTEX PHARMACEUTICALS, INC. 50 NORTHERN AVENUE BOSTON MA 02210
Business Address
Tatsis Ourania (Reporting) CIK: 0001789815 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 25629177